Judge Issues Mixed Ruling In Salix, Norwich Patent Row

By Adam Lidgett (August 11, 2022, 5:28 PM EDT) -- A Delaware federal judge has found that Norwich Pharmaceuticals Inc.'s proposed generic version of a treatment for a neurological disorder linked to liver disease would induce infringement of various Salix Pharmaceuticals Ltd. patents, but also determined that claims in other Salix patents on the product were not valid....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!